Pharmosa Biopharm Inc.

Taïwan, Province de Chine

Commandez votre montre hebdomadaire Pharmosa Biopharm Inc.
Quantité totale PI 19
Rang # Quantité totale PI 80 340
Note d'activité PI 2/5.0    14
Rang # Activité PI 61 076
Symbole boursier 6875 (tpex)
Capitalisation 7.2000003B  (TWD)

Brevets

Marques

10 0
4 0
5 0
0
 
Dernier brevet 2025 - Methods for treating systemic sc...
Premier brevet 2015 - High drug load pharmaceutical co...

Derniers inventions, produits et services

2025 Invention Methods for treating systemic sclerosis and frost bite by inhalation therapy. The present inventi...
Invention Pharmaceutical composition for controlled release of weak acid drugs and uses thereof. Provided ...
Invention Liposome compositions comprising weak acid drugs and uses thereof. The present invention relates...
2024 Invention Pharmaceutical composition of a weak acid drug and methods of administration. The present invent...
Invention Liposome compositions comprising weak acid drugs and uses thereof. The present invention relates ...
2023 Invention Pharmaceutical composition for controlled release of treprostinil. Provided herein are pharmaceu...
2021 Invention Pharmaceutical composition for controlled release of treprostinil. Provided herein are pharmaceut...
2020 Invention Pharmaceutical composition of a weak acid drug and methods of administration. The present inventi...
2019 Invention Pharmaceutical composition for controlled release of weak acid drugs and uses thereof. Provided h...
2015 Invention High drug load pharmaceutical compositions with controllable release rate and production methods ...